Logo image of EVH

EVOLENT HEALTH INC - A (EVH) Stock Fundamental Analysis

NYSE:EVH - US30050B1017 - Common Stock

8.77 USD
-0.19 (-2.12%)
Last: 8/21/2025, 8:07:14 PM
8.7799 USD
+0.01 (+0.11%)
After Hours: 8/21/2025, 8:07:14 PM
Fundamental Rating

2

EVH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. EVH has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EVH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EVH had negative earnings in the past year.
EVH had a positive operating cash flow in the past year.
EVH had negative earnings in each of the past 5 years.
In multiple years EVH reported negative operating cash flow during the last 5 years.
EVH Yearly Net Income VS EBIT VS OCF VS FCFEVH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

EVH's Return On Assets of -5.29% is fine compared to the rest of the industry. EVH outperforms 74.29% of its industry peers.
EVH's Return On Equity of -12.45% is fine compared to the rest of the industry. EVH outperforms 68.57% of its industry peers.
The Return On Invested Capital of EVH (0.85%) is better than 68.57% of its industry peers.
Industry RankSector Rank
ROA -5.29%
ROE -12.45%
ROIC 0.85%
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
EVH Yearly ROA, ROE, ROICEVH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

EVH has a better Operating Margin (0.93%) than 68.57% of its industry peers.
EVH has a Gross Margin of 15.25%. This is amonst the worse of the industry: EVH underperforms 80.00% of its industry peers.
In the last couple of years the Gross Margin of EVH has declined.
Industry RankSector Rank
OM 0.93%
PM (TTM) N/A
GM 15.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
EVH Yearly Profit, Operating, Gross MarginsEVH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

More info and screens

0

2. Health

2.1 Basic Checks

EVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, EVH has more shares outstanding
The number of shares outstanding for EVH has been increased compared to 5 years ago.
The debt/assets ratio for EVH is higher compared to a year ago.
EVH Yearly Shares OutstandingEVH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EVH Yearly Total Debt VS Total AssetsEVH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.89, we must say that EVH is in the distress zone and has some risk of bankruptcy.
EVH's Altman-Z score of 0.89 is in line compared to the rest of the industry. EVH outperforms 51.43% of its industry peers.
A Debt/Equity ratio of 0.73 indicates that EVH is somewhat dependend on debt financing.
EVH has a Debt to Equity ratio of 0.73. This is in the lower half of the industry: EVH underperforms 77.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Altman-Z 0.89
ROIC/WACC0.09
WACC9.05%
EVH Yearly LT Debt VS Equity VS FCFEVH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

EVH has a Current Ratio of 0.98. This is a bad value and indicates that EVH is not financially healthy enough and could expect problems in meeting its short term obligations.
EVH has a Current ratio of 0.98. This is in the lower half of the industry: EVH underperforms 77.14% of its industry peers.
EVH has a Quick Ratio of 0.98. This is a bad value and indicates that EVH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of EVH (0.98) is worse than 77.14% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
EVH Yearly Current Assets VS Current LiabilitesEVH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

EVH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -101.71%.
The Earnings Per Share has been growing by 220.75% on average over the past years. This is a very strong growth
Looking at the last year, EVH shows a very strong growth in Revenue. The Revenue has grown by 30.09%.
EVH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.04% yearly.
EPS 1Y (TTM)-101.71%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)30.09%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-31.34%

3.2 Future

Based on estimates for the next years, EVH will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.08% on average per year.
Based on estimates for the next years, EVH will show a small growth in Revenue. The Revenue will grow by 7.35% on average per year.
EPS Next Y-45.99%
EPS Next 2Y-4.83%
EPS Next 3Y7.03%
EPS Next 5Y18.08%
Revenue Next Year-19.65%
Revenue Next 2Y-3.54%
Revenue Next 3Y1.98%
Revenue Next 5Y7.35%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EVH Yearly Revenue VS EstimatesEVH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
EVH Yearly EPS VS EstimatesEVH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.5 -0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVH. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 14.67 indicates a correct valuation of EVH.
Based on the Price/Forward Earnings ratio, EVH is valued cheaper than 88.57% of the companies in the same industry.
EVH is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.91, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 14.67
EVH Price Earnings VS Forward Price EarningsEVH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EVH indicates a rather cheap valuation: EVH is cheaper than 88.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.58
EVH Per share dataEVH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.83%
EPS Next 3Y7.03%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EVH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVOLENT HEALTH INC - A

NYSE:EVH (8/21/2025, 8:07:14 PM)

After market: 8.7799 +0.01 (+0.11%)

8.77

-0.19 (-2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-07 2025-08-07/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners108.51%
Inst Owner Change1.94%
Ins Owners1.53%
Ins Owner Change6.87%
Market Cap1.03B
Analysts83.33
Price Target18.3 (108.67%)
Short Float %16.3%
Short Ratio6.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-185.37%
Min EPS beat(2)-332.96%
Max EPS beat(2)-37.77%
EPS beat(4)1
Avg EPS beat(4)-110.42%
Min EPS beat(4)-332.96%
Max EPS beat(4)17.44%
EPS beat(8)5
Avg EPS beat(8)0.86%
EPS beat(12)8
Avg EPS beat(12)38.86%
EPS beat(16)12
Avg EPS beat(16)463.28%
Revenue beat(2)1
Avg Revenue beat(2)1.17%
Min Revenue beat(2)-1.7%
Max Revenue beat(2)4.03%
Revenue beat(4)2
Avg Revenue beat(4)0.28%
Min Revenue beat(4)-1.9%
Max Revenue beat(4)4.03%
Revenue beat(8)5
Avg Revenue beat(8)1.03%
Revenue beat(12)7
Avg Revenue beat(12)0.95%
Revenue beat(16)10
Avg Revenue beat(16)1.14%
PT rev (1m)1.3%
PT rev (3m)0.43%
EPS NQ rev (1m)-10.31%
EPS NQ rev (3m)-26.07%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0.1%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.67
P/S 0.43
P/FCF N/A
P/OCF 55.89
P/B 0.91
P/tB N/A
EV/EBITDA 10.58
EPS(TTM)-0.02
EYN/A
EPS(NY)0.6
Fwd EY6.82%
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)0.16
OCFY1.79%
SpS20.43
BVpS9.61
TBVpS-5.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.29%
ROE -12.45%
ROCE 1.17%
ROIC 0.85%
ROICexc 0.96%
ROICexgc 51.32%
OM 0.93%
PM (TTM) N/A
GM 15.25%
FCFM N/A
ROA(3y)-3.35%
ROA(5y)-7.41%
ROE(3y)-7.16%
ROE(5y)-16.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.51%
GM growth 5Y-10.71%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF N/A
Debt/EBITDA 6.06
Cap/Depr 24.92%
Cap/Sales 1.17%
Interest Coverage 250
Cash Conversion 13.62%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z 0.89
F-Score5
WACC9.05%
ROIC/WACC0.09
Cap/Depr(3y)38.35%
Cap/Depr(5y)41.66%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.71%
EPS 3Y220.75%
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-45.99%
EPS Next 2Y-4.83%
EPS Next 3Y7.03%
EPS Next 5Y18.08%
Revenue 1Y (TTM)30.09%
Revenue growth 3Y41.17%
Revenue growth 5Y30.04%
Sales Q2Q%-31.34%
Revenue Next Year-19.65%
Revenue Next 2Y-3.54%
Revenue Next 3Y1.98%
Revenue Next 5Y7.35%
EBIT growth 1Y3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year302.75%
EBIT Next 3Y82.87%
EBIT Next 5Y55.33%
FCF growth 1Y4.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.42%
OCF growth 3Y-21.47%
OCF growth 5YN/A